ARS Pharmaceuticals, Inc.

SPRY

—

Advanced chart & tools →

ARS Pharmaceuticals, Inc.SPRY

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.74

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$84.28M

Net income

$-171.30M

Net margin

-203.3%

Gross margin

—

Dividends & financials

ARS Pharmaceuticals, Inc. (SPRY) reported revenue of $84.28M and net income of $-171.30M, or $-1.74 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.